Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - MusclePharm Corp | v321963_10q.htm |
| EX-31.2 - EXHIBIT 31.2 - MusclePharm Corp | v321963_ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - MusclePharm Corp | v321963_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - MusclePharm Corp | v321963_ex31-1.htm |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with this Quarterly Report of MusclePharm Corporation (the “Company”), on Form 10-Q for the quarter ended June 30, 2012, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, L. Gary Davis, Principal Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | Such Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in such Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: August 20, 2012 | By: | /s/ L. Gary Davis | |
| L. Gary Davis | |||
| Principal Financial Officer MusclePharm Corporation | |||